ID   AKT3_HUMAN              Reviewed;         479 AA.
AC   Q9Y243; Q0VAA6; Q5VTI1; Q5VTI2; Q96QV3; Q9UFP5;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   05-OCT-2010, entry version 113.
DE   RecName: Full=RAC-gamma serine/threonine-protein kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein kinase Akt-3;
DE   AltName: Full=Protein kinase B gamma;
DE            Short=PKB gamma;
DE   AltName: Full=RAC-PK-gamma;
DE   AltName: Full=STK-2;
GN   Name=AKT3; Synonyms=PKBG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MUTAGENESIS.
RX   MEDLINE=99194749; PubMed=10092583; DOI=10.1074/jbc.274.14.9133;
RA   Brodbeck D., Cron P., Hemmings B.A.;
RT   "A human protein kinase B gamma with regulatory phosphorylation sites
RT   in the activation loop and in the C-terminal hydrophobic domain.";
RL   J. Biol. Chem. 274:9133-9136(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=99225329; PubMed=10208883; DOI=10.1006/bbrc.1999.0559;
RA   Nakatani K., Sakaue H., Thompson D.A., Weigel R.J., Roth R.A.;
RT   "Identification of a human Akt3 (protein kinase B gamma) which
RT   contains the regulatory serine phosphorylation site.";
RL   Biochem. Biophys. Res. Commun. 257:906-910(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   MEDLINE=99421751; PubMed=10491192;
RX   DOI=10.1046/j.1432-1327.1999.00774.x;
RA   Masure S., Haefner B., Wesselink J.-J., Hoefnagel E., Mortier E.,
RA   Verhasselt P., Tuytelaars A., Gordon R., Richardson A.;
RT   "Molecular cloning, expression and characterization of the human
RT   serine/threonine kinase Akt-3.";
RL   Eur. J. Biochem. 265:353-360(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Li X., Yu L., Huang H., Zhang M., Zhao Y., Zhao S.;
RT   "Cloning of a novel human cDNA, STK-2, which encodes a rat serine-
RT   threonine protein kinase (STK) homolog.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   MEDLINE=21154917; PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND MUTAGENESIS OF
RP   THR-305 AND THR-447.
RX   PubMed=11387345; DOI=10.1074/jbc.M104633200;
RA   Brodbeck D., Hill M.M., Hemmings B.A.;
RT   "Two splice variants of PKB gamma have different regulatory capacity
RT   depending on the presence or absence of the regulatory phosphorylation
RT   site Ser-472 in the C-terminal hydrophobic domain.";
RL   J. Biol. Chem. 276:29550-29558(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   CHARACTERIZATION, AND PHOSPHORYLATION AT THR-305 BY PDPK1.
RX   PubMed=9512493;
RA   Walker K.S., Deak M., Paterson A., Hudson K., Cohen P., Alessi D.R.;
RT   "Activation of protein kinase B beta and gamma isoforms by insulin in
RT   vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro:
RT   comparison with protein kinase B alpha.";
RL   Biochem. J. 331:299-308(1998).
RN   [11]
RP   INTERACTION WITH TCL1A.
RX   PubMed=11707444; DOI=10.1074/jbc.M107069200;
RA   Laine J., Kuenstle G., Obata T., Noguchi M.;
RT   "Differential regulation of Akt kinase isoforms by the members of the
RT   TCL1 oncogene family.";
RL   J. Biol. Chem. 277:3743-3751(2002).
RN   [12]
RP   INTERACTION WITH TCL1A.
RX   PubMed=11839817; DOI=10.1128/MCB.22.5.1513-1525.2002;
RA   Kuenstle G., Laine J., Pierron G., Kagami S., Nakajima H., Hoh F.,
RA   Roumestand C., Stern M.H., Noguchi M.;
RT   "Identification of Akt association and oligomerization domains of the
RT   Akt kinase coactivator TCL1.";
RL   Mol. Cell. Biol. 22:1513-1525(2002).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120 AND SER-123, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [14]
RP   UBIQUITINATION BY TTC3.
RX   PubMed=20059950; DOI=10.1016/j.devcel.2009.09.007;
RA   Suizu F., Hiramuki Y., Okumura F., Matsuda M., Okumura A.J.,
RA   Hirata N., Narita M., Kohno T., Yokota J., Bohgaki M., Obuse C.,
RA   Hatakeyama S., Obata T., Noguchi M.;
RT   "The E3 ligase TTC3 facilitates ubiquitination and degradation of
RT   phosphorylated Akt.";
RL   Dev. Cell 17:800-810(2009).
RN   [15]
RP   INTERACTION WITH TRAF6.
RX   PubMed=19713527; DOI=10.1126/science.1175065;
RA   Yang W.-L., Wang J., Chan C.-H., Lee S.-W., Campos A.D., Lamothe B.,
RA   Hur L., Grabiner B.C., Lin X., Darnay B.G., Lin H.-K.;
RT   "The E3 ligase TRAF6 regulates Akt ubiquitination and activation.";
RL   Science 325:1134-1138(2009).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-171.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: IGF-1 leads to the activation of AKT3, which may play a
CC       role in regulating cell survival. Capable of phosphorylating
CC       several known proteins. Truncated isoform 2/PKB gamma 1 without
CC       the second serine phosphorylation site could still be stimulated
CC       but to a lesser extent.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Two specific sites, one in the kinase domain
CC       (Thr-305) and the other in the C-terminal regulatory region (Ser-
CC       472), need to be phosphorylated for its full activation (By
CC       similarity).
CC   -!- SUBUNIT: Interacts (via PH domain) with TCL1A; this enhances AKT3
CC       phosphorylation and activation. Interacts with TRAF6.
CC   -!- INTERACTION:
CC       Q16543:CDC37; NbExp=1; IntAct=EBI-296115, EBI-295634;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Membrane; Peripheral membrane
CC       protein. Note=Membrane-associated after cell stimulation leading
CC       to its translocation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PKB gamma;
CC         IsoId=Q9Y243-1; Sequence=Displayed;
CC       Name=2; Synonyms=PKB gamma 1;
CC         IsoId=Q9Y243-2; Sequence=VSP_004947;
CC   -!- TISSUE SPECIFICITY: In adult tissues, it is highly expressed in
CC       brain, lung and kidney, but weakly in heart, testis and liver. In
CC       fetal tissues, it is highly expressed in heart, liver and brain
CC       and not at all in kidney.
CC   -!- DOMAIN: Binding of the PH domain to the phosphatidylinositol 3-
CC       kinase alpha (PI(3)K) results in its targeting to the plasma
CC       membrane.
CC   -!- PTM: Phosphorylation on Thr-305 and Ser-472 is required for full
CC       activity (By similarity). Phosphorylated upon DNA damage, probably
CC       by ATM or ATR.
CC   -!- PTM: Ubiquitinated. When fully phosphorylated and translocated
CC       into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed
CC       by TTC3, leading to its degradation by the proteasome.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. RAC subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 PH domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AKT3ID615ch1q44.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF124141; AAD29089.1; -; mRNA.
DR   EMBL; AF135794; AAD24196.1; -; mRNA.
DR   EMBL; AF085234; AAL40392.1; -; mRNA.
DR   EMBL; AJ245709; CAB53537.1; -; mRNA.
DR   EMBL; AL117525; CAB55977.1; ALT_TERM; mRNA.
DR   EMBL; AY005799; AAF91073.1; -; mRNA.
DR   EMBL; AL591721; CAH71866.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH71866.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH71866.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH71866.1; JOINED; Genomic_DNA.
DR   EMBL; AL591721; CAH71867.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH71867.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH71867.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH71867.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH72891.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH72891.1; JOINED; Genomic_DNA.
DR   EMBL; AL591721; CAH72891.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH72891.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH72892.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH72892.1; JOINED; Genomic_DNA.
DR   EMBL; AL591721; CAH72892.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH72892.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH73072.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH73072.1; JOINED; Genomic_DNA.
DR   EMBL; AL591721; CAH73072.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH73072.1; JOINED; Genomic_DNA.
DR   EMBL; AL662889; CAH73073.1; -; Genomic_DNA.
DR   EMBL; AC096539; CAH73073.1; JOINED; Genomic_DNA.
DR   EMBL; AL591721; CAH73073.1; JOINED; Genomic_DNA.
DR   EMBL; AL592151; CAH73073.1; JOINED; Genomic_DNA.
DR   EMBL; CH471148; EAW77093.1; -; Genomic_DNA.
DR   EMBL; CH471148; EAW77094.1; -; Genomic_DNA.
DR   EMBL; BC121154; AAI21155.1; -; mRNA.
DR   IPI; IPI00031747; -.
DR   IPI; IPI00219411; -.
DR   PIR; A59380; A59380.
DR   PIR; T17287; T17287.
DR   RefSeq; NP_005456.1; -.
DR   RefSeq; NP_859029.1; -.
DR   UniGene; Hs.498292; -.
DR   PDB; 2X18; X-ray; 1.46 A; A/B/C/D/E/F/G/H=1-118.
DR   PDBsum; 2X18; -.
DR   ProteinModelPortal; Q9Y243; -.
DR   SMR; Q9Y243; 1-115, 142-476.
DR   IntAct; Q9Y243; 1.
DR   MINT; MINT-222821; -.
DR   STRING; Q9Y243; -.
DR   PhosphoSite; Q9Y243; -.
DR   PRIDE; Q9Y243; -.
DR   Ensembl; ENST00000263826; ENSP00000263826; ENSG00000117020.
DR   Ensembl; ENST00000366539; ENSP00000355497; ENSG00000117020.
DR   GeneID; 10000; -.
DR   KEGG; hsa:10000; -.
DR   NMPDR; fig|9606.3.peg.3340; -.
DR   UCSC; uc001hzz.1; human.
DR   UCSC; uc001iab.1; human.
DR   CTD; 10000; -.
DR   GeneCards; GC01M243653; -.
DR   HGNC; HGNC:393; AKT3.
DR   HPA; CAB013090; -.
DR   HPA; HPA026441; -.
DR   MIM; 611223; gene.
DR   PharmGKB; PA24686; -.
DR   eggNOG; prNOG15723; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q9Y243; -.
DR   OMA; IMSDVTI; -.
DR   OrthoDB; EOG97H886; -.
DR   PhylomeDB; Q9Y243; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; pi3kciaktpathway; Class I PI3K signaling events mediated by Akt.
DR   Pathway_Interaction_DB; s1p_s1p3_pathway; S1P3 pathway.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_13698; Regulation of beta-cell development.
DR   Reactome; REACT_14797; Signaling by GPCR.
DR   Reactome; REACT_604; Hemostasis.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   BindingDB; Q9Y243; -.
DR   NextBio; 37765; -.
DR   ArrayExpress; Q9Y243; -.
DR   Bgee; Q9Y243; -.
DR   CleanEx; HS_AKT3; -.
DR   Genevestigator; Q9Y243; -.
DR   GermOnline; ENSG00000117020; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR011993; PH_type.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR001849; Pleckstrin_homology.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR015744; Serine/threonine_Kinase_Rac.
DR   Gene3D; G3DSA:2.30.29.30; PH_type; 1.
DR   PANTHER; PTHR22985:SF69; Akt; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transferase;
KW   Ubl conjugation.
FT   CHAIN         1    479       RAC-gamma serine/threonine-protein
FT                                kinase.
FT                                /FTId=PRO_0000085611.
FT   DOMAIN        5    107       PH.
FT   DOMAIN      148    405       Protein kinase.
FT   DOMAIN      406    479       AGC-kinase C-terminal.
FT   NP_BIND     154    162       ATP (By similarity).
FT   ACT_SITE    271    271       Proton acceptor (By similarity).
FT   BINDING     177    177       ATP (By similarity).
FT   MOD_RES     120    120       Phosphoserine.
FT   MOD_RES     123    123       Phosphoserine.
FT   MOD_RES     305    305       Phosphothreonine; by PDPK1.
FT   MOD_RES     472    472       Phosphoserine (By similarity).
FT   VAR_SEQ     452    479       YDEDGMDCMDNERRPHFPQFSYSASGRE -> CQQSDCGML
FT                                GNWKK (in isoform 2).
FT                                /FTId=VSP_004947.
FT   VARIANT     171    171       G -> R (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040358.
FT   MUTAGEN     305    305       T->A: No activation after pervanadate
FT                                treatment.
FT   MUTAGEN     305    305       T->D: 2-fold increase of phosphorylation
FT                                steady state level, no activation after
FT                                pervanadate treatment.
FT   MUTAGEN     447    447       T->A: No effect.
FT   MUTAGEN     447    447       T->D: No effect.
FT   MUTAGEN     472    472       S->A: 67% decrease of activity after
FT                                pervanadate treatment.
FT   MUTAGEN     472    472       S->D: 1.4-fold increase of
FT                                phosphorylation steady state level, 50%
FT                                decrease of activity after pervanadate
FT                                treatment.
FT   CONFLICT    279    279       L -> R (in Ref. 9; AAI21155).
SQ   SEQUENCE   479 AA;  55775 MW;  F08BDDE6502E78FB CRC64;
     MSDVTIVKEG WVQKRGEYIK NWRPRYFLLK TDGSFIGYKE KPQDVDLPYP LNNFSVAKCQ
     LMKTERPKPN TFIIRCLQWT TVIERTFHVD TPEEREEWTE AIQAVADRLQ RQEEERMNCS
     PTSQIDNIGE EEMDASTTHH KRKTMNDFDY LKLLGKGTFG KVILVREKAS GKYYAMKILK
     KEVIIAKDEV AHTLTESRVL KNTRHPFLTS LKYSFQTKDR LCFVMEYVNG GELFFHLSRE
     RVFSEDRTRF YGAEIVSALD YLHSGKIVYR DLKLENLMLD KDGHIKITDF GLCKEGITDA
     ATMKTFCGTP EYLAPEVLED NDYGRAVDWW GLGVVMYEMM CGRLPFYNQD HEKLFELILM
     EDIKFPRTLS SDAKSLLSGL LIKDPNKRLG GGPDDAKEIM RHSFFSGVNW QDVYDKKLVP
     PFKPQVTSET DTRYFDEEFT AQTITITPPE KYDEDGMDCM DNERRPHFPQ FSYSASGRE
//
